Beam Therapeutics
Beam Therapeutics is seeking a motivated Co-op to join the Gene Editing Platform Technologies team, where the individual will assist in engineering and optimizing gene editing systems for diverse therapeutic programs. The role involves collaborating with scientists to develop experimental plans, generate reagents, evaluate performance in mammalian cell culture, and analyze data. This position offers unique exposure to Beam's research platform and therapeutic-area biology teams.
Headquarters
Cambridge, Massachusetts, United States
Company Size
501-1000 employees
Founded
2017
Beam Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, pioneering precision genetic medicines using its proprietary base editing platform to make precise single‑base DNA changes without creating double‑strand breaks. The company advances both in vivo and ex vivo programs across hematology, rare genetic diseases, and oncology, moving several candidates toward clinical development. Beam combines engineered editors, delivery technologies, and extensive safety profiling to create durable, potentially one‑time treatments and partners with academic and industry collaborators to accelerate translation.
Beam Therapeutics Stock Surges 23% in 6 Months: What's Driving It?
10 hours ago
Beam Therapeutics (BEAM) Leverages New Financing And IP Control Is Its Gene-Editing Edge Strengthening?
3 days ago
Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Beam Therapeutics.
11% above the average for this role
After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
2 weeks ago
Research Technician
University of North Carolina System
2027 Co-op in Genome Engineering & Transgenic Model Development
Regeneron Pharmaceuticals
Co-op
Kernal Biologics, Inc.
Research Associate, Gene Engineering and Delivery
Bristol Myers Squibb
Co-op: Platform Technologies & Innovation
Prime Medicine
Associate Scientist, Gene Engineering and Delivery
Bristol Myers Squibb